Stock PRM PRIM, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Prim, S.A.

Equities

PRM

ES0170884417

Medical Equipment, Supplies & Distribution

Market Closed - BME
Other stock markets
 11:35:22 2024-04-29 am EDT 		5-day change 1st Jan Change
10.25 EUR 0.00% Intraday chart for Prim, S.A. +2.50% -1.91%
Apr. 04 Prim, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 22 Primoris Services Insider Sold Shares Worth $826,144, According to a Recent SEC Filing MT

Valuation

Fiscal Period: December 2019 2021 2022 2023 2024
Capitalization 1 198.4 251.1 184.4 177.8 177.6
Enterprise Value (EV) 1 198.4 237.8 195.6 177.8 168.5
P/E ratio 17.6 x 14.4 x 21.6 x 14.1 x 9.03 x
Yield - 3.49% 4.72% - 5.54%
Capitalization / Revenue - 1.49 x 0.94 x 0.82 x 0.78 x
EV / Revenue - 1.41 x 0.99 x 0.82 x 0.74 x
EV / EBITDA - 9.81 x 11 x - 5.2 x
EV / FCF - - - - -
FCF Yield - - - - -
Price to Book - 2.06 x 1.54 x - 1.23 x
Nbr of stocks (in thousands) 17,326 17,260 17,078 17,011 17,323
Reference price 2 11.45 14.55 10.80 10.45 10.25
Announcement Date 6/8/20 2/25/22 2/28/23 4/4/24 -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2021 2022 2023 2024
Net sales 1 - 168.5 197.2 216.5 228
EBITDA 1 - 24.24 17.73 - 32.42
EBIT 1 - 17.34 9.354 16.01 23.29
Operating Margin - 10.29% 4.74% 7.4% 10.22%
Earnings before Tax (EBT) 1 - 23.06 10.93 17.03 25.79
Net income 11.22 - - - -
Net margin - - - - -
EPS 2 0.6500 1.010 0.5000 0.7400 1.135
Free Cash Flow - - - - -
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share 2 - 0.5082 0.5100 - 0.5676
Announcement Date 6/8/20 2/25/22 2/28/23 4/4/24 -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2021 2022 2023 2024
Net Debt 1 - - 11.2 - -
Net Cash position 1 - 13.3 - - 9.08
Leverage (Debt/EBITDA) - - 0.6289 x - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - 14.9% 7% - 14.3%
ROA (Net income/ Total Assets) - - - - -
Assets - - - - -
Book Value Per Share 2 - 7.050 7.000 - 8.310
Cash Flow per Share 2 - 1.420 0.2900 - 1.670
Capex - - - - -
Capex / Sales - - - - -
Announcement Date 6/8/20 2/25/22 2/28/23 4/4/24 -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Prim, S.A.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
10.25 EUR
Average target price
16.75 EUR
Spread / Average Target
+63.41%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Supplies

1st Jan change Capi.
PRIM, S.A. Stock Prim, S.A.
-1.91% 190M
COLOPLAST A/S Stock Coloplast A/S
+11.63% 27.84B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED Stock Shandong Weigao Group Medical Polymer Company Limited
-29.83% 3.04B
WINNER MEDICAL CO., LTD. Stock Winner Medical Co., Ltd.
-14.68% 2.56B
INTCO MEDICAL TECHNOLOGY CO., LTD. Stock Intco Medical Technology Co., Ltd.
+11.64% 2.33B
HARTALEGA HOLDINGS Stock Hartalega Holdings
+2.96% 1.99B
HARBIN FUERJIA TECHNOLOGY CO., LTD. Stock Harbin Fuerjia Technology Co., Ltd.
-11.65% 1.87B
TOP GLOVE CORPORATION BHD. Stock Top Glove Corporation Bhd.
-1.67% 1.49B
NAKANISHI INC. Stock Nakanishi Inc.
+2.02% 1.27B
KANGJI MEDICAL HOLDINGS LIMITED Stock Kangji Medical Holdings Limited
+3.86% 1.12B
Medical Supplies
  1. Stock Market
  2. Equities
  3. PRM Stock
  4. Financials Prim, S.A.